SLC2A1 and Duchenne muscular dystrophy: The prevalence of the glycolytic pathway in DMD hiPSC-fibs was further supported by an increased expression of glucose transporter 1 (GLUT-1), emphasizing a preponderant use of glucose for cellular metabolism in the DMD hiPSC-fibs as compared to control hiPSC-fibs (Fig. 3D).